Position in ARGX
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$491,718
+$60,871 QoQ
Shares Held
530
-10.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#303
of 506 holders
Holding Since
Sep 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MGO ONE SEVEN LLC holds $12,768,232 across 14 Biotechnology names. ARGX ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SRRK |
Scholar Rock Holding Corp
|
125,077 | $6,879,235 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,581 | $1,778,790 | |
| 3 | RLMD |
Relmada Therapeutics, Inc.
|
100,000 | $692,000 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
8,734 | $683,610 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
932 | $581,139 | |
| 6 | ARGX |
Argenx SE
This page
|
530 | $491,718 | |
| 7 | OCUL |
Ocular Therapeutix, Inc
|
45,989 | $451,611 | |
| 8 | MDWD |
MediWound Ltd.
|
22,159 | $325,737 |
All Filings in ARGX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $491,718 | 530 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $430,847 | 590 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $670,237 | 797 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $427,047 | 579 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $210,014 | 381 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $224,316 | 379 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $322,875 | 525 | Shares | Sole | 2025-02-14 | |
| 2023-12-31 | $208,856 | 549 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $234,507 | 477 | Shares | Sole | 2023-11-03 | |
| No filing history on record for this holder in this stock. | ||||||